Working… Menu

Clinical Evaluation of Safety and Tolerability of KDR2-2 Eye Drops in Healthy Volunteers With Pharmacokinetic Assessment

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT04620109
Recruitment Status : Recruiting
First Posted : November 6, 2020
Last Update Posted : November 6, 2020
Information provided by (Responsible Party):
Guangzhou HuiBoRui Biological Pharmaceutical Technology Co. Ltd

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : March 31, 2021
Estimated Study Completion Date : June 30, 2021